$Regencell Bioscience(RGC.US) dipped slightly but technical indicators are calling for a sell. It feels like the market is becoming increasingly picky about these small biotech stocks, and this kind of stock inherently requires long-term nurturing..

There's no short-term story, and capital isn't willing to hold on. No matter how good it sounds, with such high volatility, getting in is like riding a rollercoaster, it really has a gambling feel to it.

Seeing others make big money, I'm just numb. Better to watch steadily from the sidelines, can't risk my life on this.